GLENN SBLENDORIO
CIK 1277478 · Chief Executive Officer · last filed 2026-04-27
GLENN SBLENDORIO is a Chief Executive Officer who has filed 145 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider disposed of $2.1M of FOLD on Apr 27, 2026. Across all open-market trades the lifetime net is −$23.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $146.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$146.4K
7
145
-$22.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$412.0K | 26 | 2026-04-27 |
| MLYS | Director | 6,200 | $23.62 | $146.4K | $0 | 4 | 2026-02-20 |
| FDMT | Director | — | $8.83 | — | $0 | 1 | 2026-01-07 |
| IVERIC bio, Inc. (ISEE) Delisted | Chief Executive Officer | 239,275 | $39.95 | $9.56M | -$5.06M | 25 | 2023-06-26 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 31,558 | $19.00 | $599.6K | $0 | 10 | 2023-05-25 |
| IVERIC bio, Inc. (OPHT) Delisted | President and CEO | 68,105 | — | — | -$484.2K | 16 | 2019-04-03 |
| MEDICINES CO /DE (MDCO) Delisted | President & CFO | 99,805 | — | — | -$17.01M | 61 | 2015-09-04 |
Recent Filings
145 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Disp (D) | −142,564 | -$2.07M | EDGAR |
| 2026-02-20 | MLYS | Grant (A) | +6,200 | $0 | EDGAR |
| 2026-01-07 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +20,414 | $0 | EDGAR |
| 2025-02-24 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +11,847 | $0 | EDGAR |
| 2024-05-23 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Exer (M) | +15,000 | $42.0K | EDGAR |
| 2023-11-13 | — | Mixed | −31,558 | -$599.6K | |
| 2023-09-14 | MLYS | Grant (A) | — | $0 | EDGAR |